NORRIS MEDICINES LTD. - 524414 - Announcement under Regulation 30 (LODR)-Change in Management
The Company has appointed CS Priyanka Lohiya, Membership Number: A70191, as a Company Secretary, Compliance Officer and KMP of the Company.03-07-2024
03-07-2024
NORRIS MEDICINES LTD. - 524414 - Announcement under Regulation 30 (LODR)-Change in Management
As per attachment.29-06-2024
NORRIS MEDICINES LTD. - 524414 - Audited Financial Results For The Quarter And Year Ended March 31 2024
approval of audited results for the quarter and year ended March 31 2024.29-05-2024
NORRIS MEDICINES LTD. - 524414 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
1. Approval of Audited Standalone Financial Results for the quarter and year ended March 31, 2024 as per Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. 2. Approval of statement of Assets and liabilities for the year ended March 31, 2024. 3. Also note that M/s.Bahedia & Associates, Statutory auditors of the Company have issued the Audit report for the financial year ended on March 31, 2024 with unmodified opinion pursuant to regulation 33(3)(d) of the SEBI(LODR), Regulations, 2015.29-05-2024
NORRIS MEDICINES LTD. - 524414 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2024
NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve 1. To approve the Standalone Audited Financial Results as per IND-AS along with Audited Report for the quarter and year ended on 31st March, 2024. 2. To approve the Statement of Assets and Liabilities for the year ended March 31, 2024. 3. Any other business with the permission of chair.22-05-2024
NORRIS MEDICINES LTD. - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment.08-04-2024